Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The study location list was updated to add Taebuk, South Korea (28644) and remove Jungbuk, South Korea (28644); the page revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.4%
    Check dated 2026-05-18T03:24:36.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page footer to reflect a newer software/version revision (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T13:45:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T05:19:39.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' to the study's keywords.
    Difference
    0.0%
    Check dated 2026-03-28T13:51:42.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-21T08:31:21.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    No additions or deletions are observed between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.0%
    Check dated 2026-03-14T03:44:53.000Z thumbnail image

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.